Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease.

Alfieri V, Crisafulli E, Visca D, Chong WH, Stock C, Mori L, de Lauretis A, Tsipouri V, Chua F, Kouranos V, Kokosi M, Hogben C, Molyneaux PL, George PM, Maher TM, Chetta AA, Sestini P, Wells AU, Renzoni EA.

Eur Respir J. 2019 Nov 7. pii: 1901681. doi: 10.1183/13993003.01681-2019. [Epub ahead of print] No abstract available.

PMID:
31699833
2.

Results of the standard set for pulmonary sarcoidosis: feasibility and multicentre outcomes.

Kampstra NA, van der Nat PB, Dijksman LM, van Beek FT, Culver DA, Baughman RP, Renzoni EA, Wuyts W, Kouranos V, Zanen P, Wijsenbeek MS, Eijkemans MJC, Biesma DH, van der Wees PJ, Grutters JC.

ERJ Open Res. 2019 Oct 30;5(4). pii: 00094-2019. doi: 10.1183/23120541.00094-2019. eCollection 2019 Oct.

3.

Treatment of cardiac sarcoidosis.

Kouranos V, Wells AU, Sharma R.

Curr Opin Pulm Med. 2019 Sep;25(5):519-525. doi: 10.1097/MCP.0000000000000611.

PMID:
31365386
4.

Right Ventricular to Left Ventricular Ratio at CT Pulmonary Angiogram Predicts Mortality in Interstitial Lung Disease.

Bax S, Jacob J, Ahmed R, Bredy C, Dimopoulos K, Kempny A, Kokosi M, Kier G, Renzoni E, Molyneaux PL, Chua F, Kouranos V, George P, McCabe C, Wilde M, Devaraj A, Wells A, Wort SJ, Price LC.

Chest. 2019 Jul 24. pii: S0012-3692(19)31374-1. doi: 10.1016/j.chest.2019.06.033. [Epub ahead of print]

PMID:
31351047
5.

Treatment of cardiac sarcoidosis.

Kouranos V, Wells AU, Sharma R.

Curr Opin Pulm Med. 2019 Jul 24. doi: 10.1097/MCP.0000000000000611. [Epub ahead of print]

PMID:
31343492
6.

First patient-centred set of outcomes for pulmonary sarcoidosis: a multicentre initiative.

Kampstra NA, Grutters JC, van Beek FT, Culver DA, Baughman RP, Renzoni EA, Wuyts W, Kouranos V, Wijsenbeek MS, Biesma DH, van der Wees PJ, van der Nat PB.

BMJ Open Respir Res. 2019 Feb 18;6(1):e000394. doi: 10.1136/bmjresp-2018-000394. eCollection 2019.

7.

In patients with idiopathic pulmonary fibrosis the presence of hiatus hernia is associated with disease progression and mortality.

Mackintosh JA, Desai SR, Adamali H, Patel K, Chua F, Devaraj A, Kouranos V, Kokosi M, Margaritopoulos G, Renzoni EA, Wells AU, Molyneaux PL, Kumar S, Maher TM, George PM.

Eur Respir J. 2019 May 23;53(5). pii: 1802412. doi: 10.1183/13993003.02412-2018. Print 2019 May. No abstract available.

PMID:
30923184
8.

Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial.

Visca D, Mori L, Tsipouri V, Fleming S, Firouzi A, Bonini M, Pavitt MJ, Alfieri V, Canu S, Bonifazi M, Boccabella C, De Lauretis A, Stock CJW, Saunders P, Montgomery A, Hogben C, Stockford A, Pittet M, Brown J, Chua F, George PM, Molyneaux PL, Margaritopoulos GA, Kokosi M, Kouranos V, Russell AM, Birring SS, Chetta A, Maher TM, Cullinan P, Hopkinson NS, Banya W, Whitty JA, Adamali H, Spencer LG, Farquhar M, Sestini P, Wells AU, Renzoni EA.

Lancet Respir Med. 2018 Oct;6(10):759-770. doi: 10.1016/S2213-2600(18)30289-3. Epub 2018 Aug 28.

9.

New treatment paradigms for connective tissue disease-associated interstitial lung disease.

Kouranos V, Miranda G, Corte TJ, Renzoni EA.

Curr Opin Pulm Med. 2018 Sep;24(5):453-460. doi: 10.1097/MCP.0000000000000508. Review.

PMID:
30020142
10.

Why do people die from pulmonary sarcoidosis?

Kouranos V, Wells A, Walsh S.

Curr Opin Pulm Med. 2018 Sep;24(5):527-535. doi: 10.1097/MCP.0000000000000499. Review.

PMID:
30004991
11.

Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry.

Baughman RP, Shlobin OA, Wells AU, Alhamad EH, Culver DA, Barney J, Cordova FC, Carmona EM, Scholand MB, Wijsenbeek M, Ganesh S, Birring SS, Kouranos V, O'Hare L, Baran JM, Cal JG, Lower EE, Engel PJ, Nathan SD.

Respir Med. 2018 Jun;139:72-78. doi: 10.1016/j.rmed.2018.04.015. Epub 2018 May 5.

PMID:
29858005
12.

A stepwise composite echocardiographic score predicts severe pulmonary hypertension in patients with interstitial lung disease.

Bax S, Bredy C, Kempny A, Dimopoulos K, Devaraj A, Walsh S, Jacob J, Nair A, Kokosi M, Keir G, Kouranos V, George PM, McCabe C, Wilde M, Wells A, Li W, Wort SJ, Price LC.

ERJ Open Res. 2018 May 4;4(2). pii: 00124-2017. doi: 10.1183/23120541.00124-2017. eCollection 2018 Apr. Erratum in: ERJ Open Res. 2018 Jul 31;4(3):.

13.

Global longitudinal strain and long-term outcomes in asymptomatic extracardiac sarcoid patients with no apparent cardiovascular disease.

Felekos I, Aggeli C, Gialafos E, Kouranos V, Rapti A, Sfikakis P, Koulouris N, Tousoulis D.

Echocardiography. 2018 Jun;35(6):804-808. doi: 10.1111/echo.13846. Epub 2018 Feb 28.

PMID:
29490113
14.

Year in review 2017: Interstitial lung disease, pulmonary vascular disease and sleep.

Piper AJ, Wort SJ, Renzoni EA, Kouranos V.

Respirology. 2018 Apr;23(4):421-433. doi: 10.1111/resp.13273. Epub 2018 Feb 22. Review. No abstract available.

15.

Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study.

Walsh SLF, Maher TM, Kolb M, Poletti V, Nusser R, Richeldi L, Vancheri C, Wilsher ML, Antoniou KM, Behr J, Bendstrup E, Brown K, Calandriello L, Corte TJ, Cottin V, Crestani B, Flaherty K, Glaspole I, Grutters J, Inoue Y, Kokosi M, Kondoh Y, Kouranos V, Kreuter M, Johannson K, Judge E, Ley B, Margaritopoulos G, Martinez FJ, Molina-Molina M, Morais A, Nunes H, Raghu G, Ryerson CJ, Selman M, Spagnolo P, Taniguchi H, Tomassetti S, Valeyre D, Wijsenbeek M, Wuyts W, Hansell D, Wells A; IPF Project Consortium.

Eur Respir J. 2017 Aug 31;50(2). pii: 1700936. doi: 10.1183/13993003.00936-2017. Print 2017 Aug.

16.

Evaluation of visual and computer-based CT analysis for the identification of functional patterns of obstruction and restriction in hypersensitivity pneumonitis.

Jacob J, Bartholmai BJ, Brun AL, Egashira R, Rajagopalan S, Karwoski R, Kouranos V, Kokosi M, Hansell DM, Wells AU.

Respirology. 2017 Nov;22(8):1585-1591. doi: 10.1111/resp.13122. Epub 2017 Jul 11.

PMID:
28699237
17.

Search for key manifestations to predict inflammation on cardiac PET in suspected cardiac sarcoidosis population.

Kouranos V, Wechalekar K.

J Nucl Cardiol. 2019 Apr;26(2):401-404. doi: 10.1007/s12350-017-0969-x. Epub 2017 Jun 27. No abstract available.

PMID:
28656555
18.

Fibrotic Hypersensitivity Pneumonitis: Key Issues in Diagnosis and Management.

Kouranos V, Jacob J, Nicholson A, Renzoni E.

J Clin Med. 2017 Jun 15;6(6). pii: E62. doi: 10.3390/jcm6060062. Review.

19.

Complementary Role of CMR to Conventional Screening in the Diagnosis and Prognosis of Cardiac Sarcoidosis.

Kouranos V, Tzelepis GE, Rapti A, Mavrogeni S, Aggeli K, Douskou M, Prasad S, Koulouris N, Sfikakis P, Wells A, Gialafos E.

JACC Cardiovasc Imaging. 2017 Dec;10(12):1437-1447. doi: 10.1016/j.jcmg.2016.11.019. Epub 2017 Mar 15.

20.

Accurate diagnosis of cardiac sarcoidosis needs a multidisciplinary approach.

Kouranos V, Sharma R, Wells AU.

Br J Hosp Med (Lond). 2016 Nov 2;77(11):614-615. No abstract available.

PMID:
27828754
21.

Severe Sarcoidosis.

Kouranos V, Jacob J, Wells AU.

Clin Chest Med. 2015 Dec;36(4):715-26. doi: 10.1016/j.ccm.2015.08.012. Epub 2015 Oct 1. Review.

PMID:
26593144
22.

Advances in radionuclide imaging of cardiac sarcoidosis.

Kouranos V, Wells AU, Sharma R, Underwood SR, Wechalekar K.

Br Med Bull. 2015 Sep;115(1):151-63. doi: 10.1093/bmb/ldv033. Epub 2015 Aug 26. Review.

23.

Advances in imaging of cardiopulmonary involvement in sarcoidosis.

Kouranos V, Hansell DM, Sharma R, Wells AU.

Curr Opin Pulm Med. 2015 Sep;21(5):538-45. doi: 10.1097/MCP.0000000000000195. Review.

PMID:
26176968
24.

Relationship between tumor necrosis factor-α (TNFA) gene polymorphisms and cardiac sarcoidosis.

Gialafos E, Triposkiadis F, Kouranos V, Rapti A, Kosmas I, Manali E, Giamouzis G, Elezoglou A, Peros I, Anagnostopoulou O, Koulouris N, Gazouli M.

In Vivo. 2014 Nov-Dec;28(6):1125-9.

PMID:
25398810
25.

Incident atrial fibrillation in systemic sclerosis: the predictive role of B-type natriuretic peptide.

Giallafos I, Triposkiadis F, Oikonomou E, Giamouzis G, Aggeli K, Konstantopoulou P, Kouranos V, Mavrikakis M, Giallafos J, Stefanadis C, Sfikakis PP.

Hellenic J Cardiol. 2014 Jul-Aug;55(4):313-21.

26.

Myocardial stress perfusion-fibrosis imaging pattern in sarcoidosis, assessed by cardiovascular magnetic resonance imaging.

Mavrogeni S, Kouranos V, Sfikakis PP, Bratis K, Kitas GD, Manali E, Perros E, Vlasis K, Rapti A, Koulouris N, van Wijk K, Hautemann D, Reiber JH, Kolovou G, Tzelepis GE, Gialafos E.

Int J Cardiol. 2014 Mar 15;172(2):501-3. doi: 10.1016/j.ijcard.2014.01.006. Epub 2014 Jan 16. No abstract available.

PMID:
24476697
27.

Elevated pulmonary arterial systolic pressure in patients with sarcoidosis: prevalence and risk factors.

Rapti A, Kouranos V, Gialafos E, Aggeli K, Moyssakis J, Kallianos A, Kostopoulos C, Anagnostopoulou O, Sfikakis PP, Wells AU, Tzelepis GE.

Lung. 2013 Feb;191(1):61-7. doi: 10.1007/s00408-012-9442-4. Epub 2012 Dec 11.

PMID:
23229755
28.

Chemotherapy-induced neutropenia in lung cancer patients: the role of antibiotic prophylaxis.

Kouranos V, Dimopoulos G, Vassias A, Syrigos KN.

Cancer Lett. 2011 Dec 26;313(1):9-14. doi: 10.1016/j.canlet.2011.08.024. Epub 2011 Aug 27. Review.

PMID:
21955615
29.

Detection of right ventricular dysfunction by tissue Doppler imaging in asymptomatic patients with pulmonary sarcoidosis.

Gialafos E, Rapti A, Kouranos V, Aggeli K, Papaioannou TG, Kallianos A, Siasos G, Kostopoulos C, Stefanadis C.

Eur Respir J. 2011 Jan;37(1):212-5. doi: 10.1183/09031936.00065210. No abstract available.

30.

Comparison of the distribution of citations received by articles published in high, moderate, and low impact factor journals in clinical medicine.

Falagas ME, Kouranos VD, Michalopoulos A, Rodopoulou SP, Batsiou MA, Karageorgopoulos DE.

Intern Med J. 2010 Aug;40(8):587-91. doi: 10.1111/j.1445-5994.2010.02247.x.

PMID:
20718883
31.

Tuberculosis and malignancy.

Falagas ME, Kouranos VD, Athanassa Z, Kopterides P.

QJM. 2010 Jul;103(7):461-87. doi: 10.1093/qjmed/hcq068. Epub 2010 May 26. Review.

PMID:
20504861
32.

Inadequate statistical power of published comparative cohort studies on ventilator-associated pneumonia to detect mortality differences.

Falagas ME, Kouranos VD, Michalopoulos A, Rodopoulou SP, Athanasoulia AP, Karageorgopoulos DE.

Clin Infect Dis. 2010 Feb 15;50(4):468-72. doi: 10.1086/649929.

PMID:
20085466
33.

Comparison of adverse events between oral and intravenous formulations of antimicrobial agents: a systematic review of the evidence from randomized trials.

Kouranos VD, Karageorgopoulos DE, Peppas G, Falagas ME.

Pharmacoepidemiol Drug Saf. 2009 Oct;18(10):873-9. doi: 10.1002/pds.1809. Review.

PMID:
19653237
34.

Outcome of antimicrobial therapy in documented biofilm-associated infections: a review of the available clinical evidence.

Falagas ME, Kapaskelis AM, Kouranos VD, Kakisi OK, Athanassa Z, Karageorgopoulos DE.

Drugs. 2009 Jul 9;69(10):1351-61. doi: 10.2165/00003495-200969100-00005. Review.

PMID:
19583453
35.

Linezolid for patients with neutropenia: are bacteriostatic agents appropriate?

Rafailidis PI, Kouranos VD, Christodoulou C, Falagas ME.

Expert Rev Anti Infect Ther. 2009 May;7(4):415-22. doi: 10.1586/eri.09.11. Review.

PMID:
19400761
36.

Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials.

Vliagoftis H, Kouranos VD, Betsi GI, Falagas ME.

Ann Allergy Asthma Immunol. 2008 Dec;101(6):570-9. doi: 10.1016/S1081-1206(10)60219-0. Review.

PMID:
19119700
37.

Comparison of SCImago journal rank indicator with journal impact factor.

Falagas ME, Kouranos VD, Arencibia-Jorge R, Karageorgopoulos DE.

FASEB J. 2008 Aug;22(8):2623-8. doi: 10.1096/fj.08-107938. Epub 2008 Apr 11.

PMID:
18408168

Supplemental Content

Loading ...
Support Center